Agilent Technologies (A) — insider trading
Health Care
Agilent Technologies (A) has 13 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 13 (latest 2026-06-26).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-26 | KIRKWOOD JONAH PREVOST | Officer (Senior Vice President) | Shares withheld for taxes / exercise cost | 30 | $136.01 | $4.1K | Form 4 |
| 2026-06-03 | MCDONNELL PADRAIG | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 418 | $137.40 | $57.4K | Form 4 |
| 2026-05-29 | Dolsten Mikael | Director | Open-market sale | 1,600 | $135.42 | $216.7K | Form 4 |
| 2026-05-19 | Buckner Michael Steven | Officer (Senior Vice President) | Grant / award / vesting | 8,872 | $0.00 | $0 | Form 4 |
| 2026-05-08 | MAY SIMON | Officer (Senior Vice President) | Shares withheld for taxes / exercise cost | 368 | $115.62 | $42.5K | Form 4 |
| 2026-03-31 | Henson Meghan | Officer (Senior Vice President) | Shares withheld for taxes / exercise cost | 153 | $113.98 | $17.4K | Form 4 |
| 2026-03-19 | Soriot Pascal | Director | Shares withheld for taxes / exercise cost | 648 | $111.75 | $72.4K | Form 4 |
| 2026-03-19 | Soriot Pascal | Director | Grant / award / vesting | 2,158 | $111.75 | $241.2K | Form 4 |
| 2026-03-19 | SCANGOS GEORGE A | Director | Grant / award / vesting | 1,057 | $111.75 | $118.1K | Form 4 |
| 2026-03-19 | SCANGOS GEORGE A | Director | Grant / award / vesting | 2,158 | $111.75 | $241.2K | Form 4 |
| 2026-03-19 | BRAWLEY OTIS W | Director | Grant / award / vesting | 888 | $111.75 | $99.2K | Form 4 |
| 2026-03-19 | BRAWLEY OTIS W | Director | Grant / award / vesting | 2,158 | $111.75 | $241.2K | Form 4 |
| 2026-03-19 | Rataj Sue H. | Director | Grant / award / vesting | 2,158 | $111.75 | $241.2K | Form 4 |
Ask the chat about A's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Agilent Technologies (A).
Last updated 2026-06-26 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.